These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1545388)

  • 21. Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption.
    Neuwelt EA; Barnett PA; Hellström I; Hellström KE; Beaumier P; McCormick CI; Weigel RM
    Cancer Res; 1988 Sep; 48(17):4725-9. PubMed ID: 3409213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot pharmacokinetic study of tricyclic antidepressant ovine Fab for TCA poisoning in children.
    Yalindağ-Oztürk N; Goto CS; Shepherd G; Torres ON; Giroir B
    Clin Toxicol (Phila); 2010 Jun; 48(5):418-23. PubMed ID: 20524830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of an enzyme-linked immunosorbent assay to study the disposition of sheep digoxin-specific immunoglobulin G and Fab fragments in the rat.
    Johnston PC; Stevenson IH; Hewick DS
    Clin Exp Immunol; 1988 Dec; 74(3):489-93. PubMed ID: 3233793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fab fragments of ovine antibody to colchicine enhance its clearance in the rat.
    Peake PW; Pianta TJ; Succar L; Fernando M; Buckley NA; Endre ZH
    Clin Toxicol (Phila); 2015 Jun; 53(5):427-32. PubMed ID: 25858137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and toxicity of high doses of antibody Fab fragments in rats.
    Pentel PR; Keyler DE; Gilbertson DG; Ruth G; Pond SM
    Drug Metab Dispos; 1988; 16(1):141-5. PubMed ID: 2894943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab')2-scorpion venom interactions.
    Pépin-Covatta S; Lutsch C; Grandgeorge M; Lang J; Scherrmann JM
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):272-7. PubMed ID: 8917700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysine reduces renal accumulation of radioactivity associated with injection of the [177Lu]alpha-[2-(4-aminophenyl) ethyl]-1,4,7,10-tetraaza-cyclodecane-1,4,7,10-tetraacetic acid-CC49 Fab radioimmunoconjugate.
    DePalatis LR; Frazier KA; Cheng RC; Kotite NJ
    Cancer Res; 1995 Nov; 55(22):5288-95. PubMed ID: 7585590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of biodistribution of 791T/36 monoclonal antibody and its Fab/c fragment in BALB/c mice and nude mice bearing human tumor xenografts.
    Demignot S; Pimm MV; Baldwin RW
    Cancer Res; 1990 May; 50(10):2936-42. PubMed ID: 2334894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic disposition and toxicity of cationized goat immunoglobulin G and fab fragments in isolated perfused rat liver.
    Hong G; Bazin-Redureau M; Gires P; Scherrmann JM
    Drug Metab Dispos; 1998 Jul; 26(7):661-9. PubMed ID: 9660848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interspecies scaling of clearance and volume of distribution for horse antivenom F(ab')2.
    Bazin-Redureau M; Pepin S; Hong G; Debray M; Scherrmann JM
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):295-300. PubMed ID: 9653060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.
    Rao GS; Ramesh S; Ahmad AH; Tripathi HC; Sharma LD; Malik JK
    Vet J; 2002 Jan; 163(1):85-93. PubMed ID: 11749141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of goat colchicine specific antibodies on murine colchicine disposition.
    Terrien N; Urtizberea M; Scherrmann JM
    Toxicology; 1989 Nov; 59(1):11-22. PubMed ID: 2815097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of desipramine toxicity in rats using drug-specific antibody Fab' fragment: effects on hypotension and interaction with sodium bicarbonate.
    Brunn GJ; Keyler DE; Pond SM; Pentel PR
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1392-9. PubMed ID: 1312169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of colchicine-specific active immunization on colchicine toxicity and disposition in the rabbit.
    Scherrmann JM; Urtizberea M; Pierson P; Terrien N
    Toxicology; 1989 Jun; 56(2):213-22. PubMed ID: 2734802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced cellular uptake and transport of polyclonal immunoglobulin G and fab after their cationization.
    Hong G; Chappey O; Niel E; Scherrmann JM
    J Drug Target; 2000; 8(2):67-77. PubMed ID: 10852339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-colchicine Fab fragments prevent lethal colchicine toxicity in a porcine model: a pharmacokinetic and clinical study.
    Eddleston M; Fabresse N; Thompson A; Al Abdulla I; Gregson R; King T; Astier A; Baud FJ; Clutton RE; Alvarez JC
    Clin Toxicol (Phila); 2018 Aug; 56(8):773-781. PubMed ID: 29334816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicokinetics of colchicine in humans: analysis of tissue, plasma and urine data in ten cases.
    Rochdi M; Sabouraud A; Baud FJ; Bismuth C; Scherrmann JM
    Hum Exp Toxicol; 1992 Nov; 11(6):510-6. PubMed ID: 1361141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brief report: treatment of severe colchicine overdose with colchicine-specific Fab fragments.
    Baud FJ; Sabouraud A; Vicaut E; Taboulet P; Lang J; Bismuth C; Rouzioux JM; Scherrmann JM
    N Engl J Med; 1995 Mar; 332(10):642-5. PubMed ID: 7845428
    [No Abstract]   [Full Text] [Related]  

  • 40. The plasma disposition and renal elimination of digoxin-specific Fab fragments and digoxin in the rabbit.
    Timsina MP; Hewick DS
    J Pharm Pharmacol; 1992 Oct; 44(10):796-800. PubMed ID: 1360503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.